Cas9 Nucleasefrom GeneOn |
|
310 | 2x40µg (2x250 pmol): 316.80 EUR | |
Cas9 Nucleasefrom GeneOn |
|
312HC | 80 µg (500 pmol): 268.80 EUR | |
Cas9 Nucleasefrom GeneOn |
|
314HC | 400 µg (2500 pmol): 894.00 EUR | |
Cas9 Nucleasefrom Vazyme |
|
EN301-01 | 50 pmol: 146.40 EUR | |
Cas9 Nucleasefrom Vazyme |
|
EN301-02 | 250 pmol: 184.80 EUR | |
Nuclease AWAYfrom Biomatik Corporation |
|
A6257-100ML | 100ML: 22.00 EUR | |
Description: Biotechnology |
|
Nuclease AWAYfrom Biomatik Corporation |
|
A6257-500ML | 500ML: 88.00 EUR | |
Description: Biotechnology |
|
Turbo Nucleasefrom Jena Bioscience GmbH |
|
EN-180L | 5 x 10000units: 384.50 EUR | |
Description: Serratia marcescens, recombinant, E. coli |
|
Turbo Nucleasefrom Jena Bioscience GmbH |
|
EN-180S | 10000units: 96.20 EUR | |
Description: Serratia marcescens, recombinant, E. coli |
|
Ultra Nucleasefrom HZymes Biotechnology |
|
HBP000106 | 20μL: 14.73 EUR | |
Ultra Nucleasefrom HZymes Biotechnology |
|
HBP000107 | 200μL: 116.82 EUR | |
Ultra Nucleasefrom HZymes Biotechnology |
|
HBP000108 | 2mL: 965.04 EUR | |
Ultra Nucleasefrom HZymes Biotechnology |
|
HBP000109 | 20mL: 8634.56 EUR | |
Microccal Nucleasefrom Tribioscience |
|
TBS6020 | 10KU: 89.00 EUR | |
Water, Nuclease Freefrom Glycomatrix |
|
42300012-1 | 1 L: 60.10 EUR | |
Water, Nuclease Freefrom Glycomatrix |
|
42300012-2 | 4 L: 81.44 EUR | |
Water, Nuclease Freefrom Glycomatrix |
|
42300012-3 | 125 mL: 10.94 EUR | |
Water, Nuclease Freefrom Glycomatrix |
|
42300012-4 | 250 mL: 18.58 EUR | |
Water, Nuclease Freefrom Glycomatrix |
|
42300012-5 | 500 mL: 33.95 EUR | |
Water, Nuclease Freefrom Glycomatrix |
|
42300012-8 | 8 L: 173.72 EUR | |
Nuclease-free H2Ofrom Abclonal |
|
RK20102 | 25mL: 21.50 EUR | |
Nuclease P1 Antibodyfrom Abbexa |
|
20-abx300888 | [ 100 ug: Ask for price ] [ 1 mg: Ask for price ] [ 200 ug: Ask for price ] [ 20 ug: Ask for price ] [ 50 ug: Ask for price ] | |
Nuclease P1 Antibodyfrom Cusabio |
|
1-CSB-PA328459LA01PEU | [ 100ug: Ask for price ] [ 50ug: Ask for price ] | |
Description: A polyclonal antibody against Nuclease P1. Recognizes Nuclease P1 from Penicillium citrinum. This antibody is Unconjugated. Tested in the following application: ELISA |
|
Benzonase Nuclease, 99%from ProSpec Tany |
|
enz-1112 | 5000U: 90.00 EUR | |
Description: Recombinant Serratia Marcescens Benzonase Nuclease, 99% |
|
Benzonase Nuclease, 90%from ProSpec Tany |
|
enz-1150 | 5000U: 70.00 EUR | |
Description: Recombinant Serratia Marcescens Benzonase Nuclease, 90% |
|
Cas9 Nuclease Proteinfrom ABM |
|
K008 | 8.0 µg (50pmol) Volume: 50µL: 40.00 EUR | |
Description: The Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9 system is the latest RNA-guided, endonuclease tool in genome editing which allows for very specific genomic disruption and replacement. ;;The Cas9 nuclease serves to unwind the genomic DNA duplex next to conserved protospacer adjacent motifs (PAMs) and homes in on its target sequence, which is recognized by a complementary single-guide RNA. The resulting double-stranded break gets repaired by the non-homologous end joining (NHEJ) pathway, leading to a disruption in the open reading frame of the targeted gene. Alternatively, by supplying a suitable repair template, virtually any desired point mutation can be introduced at the break point via homology-directed repair (HDR).;;The Cas9 nuclease from the bacteria Streptococcus pyogenes, abbreviated spCas9, is the most commonly used Cas9 variant. The reason for spCas9 popularity is two-fold. First the spCas9 PAM sequence is 5’-NGG, which is highly abundant in the genome allowing virtually any gene to be targeted. The spCas9 enzyme also has on average a higher efficiency in vivo compared to other variants. |
|
saCas9 Nuclease Proteinfrom ABM |
|
K044 | 6.5 µg (50pmol) Volume: 50µL: 55.00 EUR | |
Description: The Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9 system is the latest RNA-guided endonuclease tool in genome editing which allows for very specific genomic disruption and replacement. ;;The Cas9 nuclease serves to unwind the genomic DNA duplex next to conserved protospacer adjacent motifs (PAMs) and homes in on its target sequence, which is recognized by a complementary single-guide RNA. The resulting double-stranded break gets repaired by the non-homologous end joining (NHEJ) pathway, leading to a disruption in the open reading frame of the targeted gene. Alternatively, by supplying a suitable repair template, virtually any desired point mutation can be introduced at the break point via homology-directed repair (HDR).;;The Cas9 nuclease from the bacteria Staphylococcus aureus, abbreviated saCas9, is gaining popularity as an alternative to spCas9 due to its relatively smaller size. The saCas9 PAM sequence is 5’-NNGRRN (preferably 5’-NNGRRT). |
|
Cas9 Nuclease - 400µg - 1,600 ng/µlfrom Intact Genomics |
|
3276-(HC) | 1/EA: 678.00 EUR | |
Cas9 Nuclease Lentivirusfrom ABM |
|
K003 | 300 µl, 10^7 IU/ml, Titer: 10^7 IU/ml: 315.00 EUR | |
Description: N/A |
|
Cas9 Nuclease Adenovirusfrom ABM |
|
K004 | 1.0 ml, 10^6 pfu/ml, Titer: 10^6 pfu/ml: 315.00 EUR | |
Description: N/A |
|
Nuclease Mix 0.5mL - EACHfrom Scientific Laboratory Supplies |
|
80650142 | EACH: 191.70 EUR | |
Cas9 Nuclease - 80µg - 1,600 ng/µlfrom Intact Genomics |
|
3273-(HC) | 1/EA: 226.80 EUR | |
Nuclease P1 Antibody (HRP)from Abbexa |
|
20-abx300889 | [ 100 ug: Ask for price ] [ 1 mg: Ask for price ] [ 200 ug: Ask for price ] [ 20 ug: Ask for price ] [ 50 ug: Ask for price ] | |
Nuclease P1 Antibody (FITC)from Abbexa |
|
20-abx300890 | [ 100 ug: Ask for price ] [ 1 mg: Ask for price ] [ 200 ug: Ask for price ] [ 20 ug: Ask for price ] [ 50 ug: Ask for price ] | |
Cas9 Nuclease NLS Proteinfrom ABM |
|
K030 | 8.0 µg (50pmol) Volume: 50µL: 40.00 EUR | |
Description: The Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9 system is the latest RNA-guided, endonuclease tool in genome editing which allows for very specific genomic disruption and replacement. ;;The Cas9 nuclease serves to unwind the genomic DNA duplex next to conserved protospacer adjacent motifs (PAMs) and homes in on its target sequence, which is recognized by a complementary single-guide RNA. The resulting double-stranded break gets repaired by the non-homologous end joining (NHEJ) pathway, leading to a disruption in the open reading frame of the targeted gene. Alternatively, by supplying a suitable repair template, virtually any desired point mutation can be introduced at the break point via homology-directed repair (HDR).;;The Cas9 nuclease from the bacteria Streptococcus pyogenes, abbreviated spCas9, is the most commonly used Cas9 variant. The reason for spCas9 popularity is two-fold. First the spCas9 PAM sequence is 5’-NGG, which is highly abundant in the genome allowing virtually any gene to be targeted. The spCas9 enzyme also has on average a higher efficiency in vivo compared to other variants. Cas9 Nuclease NLS contains a SV40 T antigen nuclear localization sequence (NLS) on the C-terminus of the protein. |
|
Rabbit polyclonal antibody to Apoptosis-enhancing nuclease (apoptosis enhancing nuclease)from Origene Technologies GmbH |
|
TA308608 | 100 µl: Ask for price | |
Nuclease P1 Antibody (Biotin)from Abbexa |
|
20-abx300891 | [ 100 ug: Ask for price ] [ 1 mg: Ask for price ] [ 200 ug: Ask for price ] [ 20 ug: Ask for price ] [ 50 ug: Ask for price ] | |
fnCpf1 Nuclease NLS Proteinfrom ABM |
|
K087 | 38 μg (250 pmol) Volume: 25µL: 75.00 EUR | |
Description: Using Cpf1 (a.k.a. Cas12a) in your CRISPR experiment offers several advantages over other CRISPR-associated nucleases.;
|
|
Nuclease Decontamination Solutionfrom Glycomatrix |
|
43094006-1 | 250 mL: 43.46 EUR | |
Universal Nuclease ELISA Kitfrom Abclonal |
|
RK04660 | 96T: 280.00 EUR | |
Bovine Albumin Nuclease Freefrom Innovative research |
|
IBOALBNF100MG | each: 136.00 EUR | |
Description: Bovine Albumin Nuclease Free |
|
Bovine Albumin Nuclease Freefrom Innovative research |
|
IBOALBNF500MG | each: 347.00 EUR | |
Description: Bovine Albumin Nuclease Free |
|
Recombinant Human APEX nuclease-1from CHI Scientific |
|
7-02476 | 2µg: Ask for price | |
Recombinant Human APEX nuclease-1from CHI Scientific |
|
7-02477 | 10µg: Ask for price | |
Recombinant Human APEX nuclease-1from CHI Scientific |
|
7-02478 | 1mg: Ask for price | |
Nuclease P1 Polyclonal Antibodyfrom EpiGentek |
|
A64318 | [ 100 µg: Ask for price ] [ 20 ul: Ask for price ] [ 50 ul: Ask for price ] [ 100 ul: Ask for price ] | |
Cas9 Nuclease Lentiviral Vectorfrom ABM |
|
K002 | 10 ug: 135.00 EUR | |
Description: N/A |
|
Penicillium citrinum Nuclease P1from Cusabio |
|
1-CSB-YP328459PEU | [ 100ug: Ask for price ] [ 10ug: Ask for price ] [ 1MG: Ask for price ] [ 200ug: Ask for price ] [ 500ug: Ask for price ] [ 50ug: Ask for price ] | |
Description: Recombinant Penicillium citrinum Nuclease P1 expressed in Yeast |
|
Penicillium citrinum Nuclease P1from Cusabio |
|
1-CSB-EP328459PEU | [ 100ug: Ask for price ] [ 10ug: Ask for price ] [ 1MG: Ask for price ] [ 200ug: Ask for price ] [ 500ug: Ask for price ] [ 50ug: Ask for price ] | |
Description: Recombinant Penicillium citrinum Nuclease P1 expressed in E.coli |
|
Penicillium citrinum Nuclease P1from Cusabio |
|
1-CSB-EP328459PEUa0 | [ 100ug: Ask for price ] [ 10ug: Ask for price ] [ 1MG: Ask for price ] [ 200ug: Ask for price ] [ 500ug: Ask for price ] [ 50ug: Ask for price ] | |
Description: Recombinant Penicillium citrinum Nuclease P1 expressed in E.coli |
|
GENIUS™Nuclease DMF Filedfrom ACROBIOSYSTEMS |
|
BEE-N3116 | 500KU: 96.30 EUR | |
Description: GENIUS™Nuclease is a recombinant form of Serratia macescens extracellular endonuclease produced in Escherichia coli cells using a proprietary process at ACRObiosystems. GENIUS™Nuclease is a homodimer with monomer molecular masses about 30 kDa. Two disulfide bonds found in the nuclease are crucial to its activity and stability. The enzyme is a non-specific nuclease with high specific activity, which degrades both single- and double-stranded nucleic acids in any form ( single stranded, double stranded, linear, circular and supercoiled ). It hydrolyzes internal phosphodiester bonds present between the nucleotides to 5‘- phosphorylated oligonucleotides of 3-5 bases in length. |
|
Cas9 Nuclease GFP NLS Proteinfrom ABM |
|
K048 | 9.5 µg (50pmol) Volume: 50µL: 55.00 EUR | |
Description: The Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9 system is the latest RNA-guided, endonuclease tool in genome editing which allows for very specific genomic disruption and replacement. ;The Cas9 nuclease serves to unwind the genomic DNA duplex next to conserved protospacer adjacent motifs (PAMs) and homes in on its target sequence, which is recognized by a complementary single-guide RNA. The resulting double-stranded break gets repaired by the non-homologous end joining (NHEJ) pathway, leading to a disruption in the open reading frame of the targeted gene. Alternatively, by supplying a suitable repair template, virtually any desired point mutation can be introduced at the break point via homology-directed repair (HDR). ;The Cas9 from the bacteria Streptococcus pyogenes, abbreviated spCas9, is the most commonly used Cas9 variant. ;The fusion of Cas9 Nuclease NLS to GFP allows for visual confirmation of transfection as well as subsequent verification of Cas9 clearance from the cells. Cas9 Nuclease-GFP can also be used for FACS applications and screening. Cas9 Nuclease-GFP NLS contains a SV40 T antigen nuclear localization sequence (NLS) on the C-terminus of the protein. Our Cas9-GFP proteins have the Enhanced green fluorescent protein (eGFP). |
|
Ultra Nuclease Assay Kit(ELISA)from HZymes Biotechnology |
|
HBP000111 | 96 Tests: 609.50 EUR | |
saCas9 Nuclease AAV Virus (AAV4)from ABM |
|
K211 | 2 x 250 µl, 1 x 10^9 GC/ml, Titer: 1 x 10^9 GC/ml: 375.00 EUR | |
Description: This AAV vector expresses the Cas9 orthologue from Staphylococcus Aureus (saCas9). saCas9 is ~1 kb shorter than spCas9, allowing it to be efficiently packaged in AAV Virus. Furthermore, the saCas9 enzyme recognizes a longer PAM sequence than spCas9, and thus has greater editing specificity.AAV has low immunogenicity and broad host range, making it an ideal choice for both in vivo and in vitro applications. Use this saCas9-expressing AAV virus with a target-specific saCas9-compatible sgRNA for highly specific and efficient genome editing. |
|
saCas9 Nuclease AAV Virus (AAV5)from ABM |
|
K212 | 2 x 250 µl, 1 x 10^9 GC/ml, Titer: 1 x 10^9 GC/ml: 375.00 EUR | |
Description: This AAV vector expresses the Cas9 orthologue from Staphylococcus Aureus (saCas9). saCas9 is ~1 kb shorter than spCas9, allowing it to be efficiently packaged in AAV Virus. Furthermore, the saCas9 enzyme recognizes a longer PAM sequence than spCas9, and thus has greater editing specificity.AAV has low immunogenicity and broad host range, making it an ideal choice for both in vivo and in vitro applications. Use this saCas9-expressing AAV virus with a target-specific saCas9-compatible sgRNA for highly specific and efficient genome editing. |
|
saCas9 Nuclease AAV Virus (AAV1)from ABM |
|
K208 | 2 x 250 µl, 1 x 10^9 GC/ml, Titer: 1 x 10^9 GC/ml: 375.00 EUR | |
Description: This AAV vector expresses the Cas9 orthologue from Staphylococcus Aureus (saCas9). saCas9 is ~1 kb shorter than spCas9, allowing it to be efficiently packaged in AAV Virus. Furthermore, the saCas9 enzyme recognizes a longer PAM sequence than spCas9, and thus has greater editing specificity.AAV has low immunogenicity and broad host range, making it an ideal choice for both in vivo and in vitro applications. Use this saCas9-expressing AAV virus with a target-specific saCas9-compatible sgRNA for highly specific and efficient genome editing. |
|
saCas9 Nuclease AAV Virus (AAV2)from ABM |
|
K209 | 2 x 250 µl, 1 x 10^9 GC/ml, Titer: 1 x 10^9 GC/ml: 375.00 EUR | |
Description: This AAV vector expresses the Cas9 orthologue from Staphylococcus Aureus (saCas9). saCas9 is ~1 kb shorter than spCas9, allowing it to be efficiently packaged in AAV Virus. Furthermore, the saCas9 enzyme recognizes a longer PAM sequence than spCas9, and thus has greater editing specificity.AAV has low immunogenicity and broad host range, making it an ideal choice for both in vivo and in vitro applications. Use this saCas9-expressing AAV virus with a target-specific saCas9-compatible sgRNA for highly specific and efficient genome editing. |
|
saCas9 Nuclease AAV Virus (AAV3)from ABM |
|
K210 | 2 x 250 µl, 1 x 10^9 GC/ml, Titer: 1 x 10^9 GC/ml: 375.00 EUR | |
Description: This AAV vector expresses the Cas9 orthologue from Staphylococcus Aureus (saCas9). saCas9 is ~1 kb shorter than spCas9, allowing it to be efficiently packaged in AAV Virus. Furthermore, the saCas9 enzyme recognizes a longer PAM sequence than spCas9, and thus has greater editing specificity.AAV has low immunogenicity and broad host range, making it an ideal choice for both in vivo and in vitro applications. Use this saCas9-expressing AAV virus with a target-specific saCas9-compatible sgRNA for highly specific and efficient genome editing. |
|
saCas9 Nuclease AAV Virus (AAV6)from ABM |
|
K213 | 2 x 250 µl, 1 x 10^9 GC/ml, Titer: 1 x 10^9 GC/ml: 375.00 EUR | |
Description: This AAV vector expresses the Cas9 orthologue from Staphylococcus Aureus (saCas9). saCas9 is ~1 kb shorter than spCas9, allowing it to be efficiently packaged in AAV Virus. Furthermore, the saCas9 enzyme recognizes a longer PAM sequence than spCas9, and thus has greater editing specificity.AAV has low immunogenicity and broad host range, making it an ideal choice for both in vivo and in vitro applications. Use this saCas9-expressing AAV virus with a target-specific saCas9-compatible sgRNA for highly specific and efficient genome editing. |
|
saCas9 Nuclease AAV Virus (AAV7)from ABM |
|
K214 | 2 x 250 µl, 1 x 10^9 GC/ml, Titer: 1 x 10^9 GC/ml: 375.00 EUR | |
Description: This AAV vector expresses the Cas9 orthologue from Staphylococcus Aureus (saCas9). saCas9 is ~1 kb shorter than spCas9, allowing it to be efficiently packaged in AAV Virus. Furthermore, the saCas9 enzyme recognizes a longer PAM sequence than spCas9, and thus has greater editing specificity.AAV has low immunogenicity and broad host range, making it an ideal choice for both in vivo and in vitro applications. Use this saCas9-expressing AAV virus with a target-specific saCas9-compatible sgRNA for highly specific and efficient genome editing. |
|
saCas9 Nuclease AAV Virus (AAV8)from ABM |
|
K215 | 2 x 250 µl, 1 x 10^9 GC/ml, Titer: 1 x 10^9 GC/ml: 375.00 EUR | |
Description: This AAV vector expresses the Cas9 orthologue from Staphylococcus Aureus (saCas9). saCas9 is ~1 kb shorter than spCas9, allowing it to be efficiently packaged in AAV Virus. Furthermore, the saCas9 enzyme recognizes a longer PAM sequence than spCas9, and thus has greater editing specificity.AAV has low immunogenicity and broad host range, making it an ideal choice for both in vivo and in vitro applications. Use this saCas9-expressing AAV virus with a target-specific saCas9-compatible sgRNA for highly specific and efficient genome editing. |
|
saCas9 Nuclease AAV Virus (AAV9)from ABM |
|
K216 | 2 x 250 µl, 1 x 10^9 GC/ml, Titer: 1 x 10^9 GC/ml: 375.00 EUR | |
Description: This AAV vector expresses the Cas9 orthologue from Staphylococcus Aureus (saCas9). saCas9 is ~1 kb shorter than spCas9, allowing it to be efficiently packaged in AAV Virus. Furthermore, the saCas9 enzyme recognizes a longer PAM sequence than spCas9, and thus has greater editing specificity.AAV has low immunogenicity and broad host range, making it an ideal choice for both in vivo and in vitro applications. Use this saCas9-expressing AAV virus with a target-specific saCas9-compatible sgRNA for highly specific and efficient genome editing. |
|
anti-Apoptosis enhancing nucleasefrom Abfrontier |
|
YF-PA20583 | 50 ug: 435.60 EUR | |
Description: Mouse polyclonal to Apoptosis enhancing nuclease |
|
saCas9 Nuclease AAV Virus (AAV10)from ABM |
|
K217 | 2 x 250 µl, 1 x 10^9 GC/ml, Titer: 1 x 10^9 GC/ml: 375.00 EUR | |
Description: This AAV vector expresses the Cas9 orthologue from Staphylococcus Aureus (saCas9). saCas9 is ~1 kb shorter than spCas9, allowing it to be efficiently packaged in AAV Virus. Furthermore, the saCas9 enzyme recognizes a longer PAM sequence than spCas9, and thus has greater editing specificity.AAV has low immunogenicity and broad host range, making it an ideal choice for both in vivo and in vitro applications. Use this saCas9-expressing AAV virus with a target-specific saCas9-compatible sgRNA for highly specific and efficient genome editing. |
|
saCas9 Nuclease AAV Virus (AAV11)from ABM |
|
K218 | 2 x 250 µl, 1 x 10^9 GC/ml, Titer: 1 x 10^9 GC/ml: 375.00 EUR | |
Description: This AAV vector expresses the Cas9 orthologue from Staphylococcus Aureus (saCas9). saCas9 is ~1 kb shorter than spCas9, allowing it to be efficiently packaged in AAV Virus. Furthermore, the saCas9 enzyme recognizes a longer PAM sequence than spCas9, and thus has greater editing specificity.AAV has low immunogenicity and broad host range, making it an ideal choice for both in vivo and in vitro applications. Use this saCas9-expressing AAV virus with a target-specific saCas9-compatible sgRNA for highly specific and efficient genome editing. |
|
Cas9 Nuclease Non-Viral Vectorfrom ABM |
|
K095 | 10 μg, Titer: N/A: 135.00 EUR | |
Description: N/A |
|
GENIUS™ Nuclease, premium gradefrom ACROBIOSYSTEMS |
|
NUE-S5119 | 5000KU: 1358.90 EUR | |
Description: GENIUS™ Nuclease, premium grade is a tag free recombinant form of Serratia marcescens extracellular endonuclease produced in Escherichia coli cells using a proprietary process at ACRObiosystems. GENIUS™ Nuclease, premium grade is a homodimer with monomer molecular masses about 30 kDa with an isoelectric point (pI) at pH 6.85. The enzyme is a non-specific nuclease with high specific activity, which degrades both single- and double-stranded nucleic acids in any form (single stranded, double stranded, linear, circular and supercoiled). It hydrolyzes internal phosphodiester bonds present between the nucleotides to 5’- phosphorylated oligonucleotides of 3-5 bases in length. |
|
Apoptosis enhancing nuclease antibodyfrom Fitzgerald |
|
70R-13466 | 100 ul: 550.00 EUR | |
Description: Affinity purified Rabbit polyclonal Apoptosis enhancing nuclease antibody |
|
Rat APEX Nuclease 1 ELISA Kitfrom Innovative research |
|
IRTAPEX1KT | each: 790.00 EUR | |
Description: Rat APEX Nuclease 1 ELISA Kit |
|
Apoptosis-enhancing nuclease antibodyfrom SAB |
|
22725 | 100ul: 479.00 EUR | |
Apoptosis-enhancing nuclease antibodyfrom SAB |
|
22725-100ul | 100ul: 468.00 EUR | |
NLS-Cas12a Nuclease (MALS verified)from ACROBIOSYSTEMS |
|
CAA-L5149 | 100ug: 107.00 EUR | |
Description: NLS-Cas12a Nuclease (CAA-L5149) is expressed from E. coli cells. It contains AA Ser 2 - His 1228 (Accession # QWN56480.1). |
|
Nuclease P1 Antibody, HRP conjugatedfrom Cusabio |
|
1-CSB-PA328459LB01PEU | [ 100ug: Ask for price ] [ 50ug: Ask for price ] | |
Description: A polyclonal antibody against Nuclease P1. Recognizes Nuclease P1 from Penicillium citrinum. This antibody is HRP conjugated. Tested in the following application: ELISA |
|
GMP GENIUS™Nuclease DMF Filedfrom ACROBIOSYSTEMS |
|
GMP-NUES19 | 5000KU: 2011.60 EUR | |
Description: GMP GENIUS™Nuclease DMF Filed is a tag free recombinant form of Serratia marcescens extracellular endonuclease produced in Escherichia coli cells using a proprietary process at ACRObiosystems. GMP GENIUSNuclease DMF Filed is a homodimer with monomer molecular masses about 30 kDa with an isoelectric point (pI) at pH 6.85. The enzyme is a non-specific nuclease with high specific activity, which degrades both single- and double-stranded nucleic acids in any form (single stranded, double stranded, linear, circular and supercoiled). It hydrolyzes internal phosphodiester bonds present between the nucleotides to 5’- phosphorylated oligonucleotides of 3-5 bases in length. |
|
Mouse APEX Nuclease 1 ELISA Kitfrom Innovative research |
|
IMSAPEX1KT | each: 752.00 EUR | |
Description: Mouse APEX Nuclease 1 ELISA Kit |
|
Human APEX Nuclease 1 ELISA Kitfrom Innovative research |
|
IHUAPEX1KT | each: 733.00 EUR | |
Description: Human APEX Nuclease 1 ELISA Kit |
|
Nuclease P1 Antibody, FITC conjugatedfrom Cusabio |
|
1-CSB-PA328459LC01PEU | [ 100ug: Ask for price ] [ 50ug: Ask for price ] | |
Description: A polyclonal antibody against Nuclease P1. Recognizes Nuclease P1 from Penicillium citrinum. This antibody is FITC conjugated. Tested in the following application: ELISA |
|
Ultra Nuclease Assay Kit 2.0(ELISA)from HZymes Biotechnology |
|
HBP000116 | 96 Tests: 609.50 EUR | |
Cas9 Nuclease NLS Protein (Lyophilized)from ABM |
|
K150 | 40µg (250pmol): 80.00 EUR | |
Description: The Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9 system is the latest RNA-guided, endonuclease tool in genome editing which allows for very specific genomic disruption and replacement. The Cas9 nuclease serves to unwind the genomic DNA duplex next to conserved protospacer adjacent motifs (PAMs) and homes in on its target sequence, which is recognized by a complementary single-guide RNA. The resulting double-stranded break gets repaired by the non-homologous end joining (NHEJ) pathway, leading to a disruption in the open reading frame of the targeted gene. Alternatively, by supplying a suitable repair template, virtually any desired point mutation can be introduced at the break point via homology-directed repair (HDR).The Cas9 nuclease from the bacteria Streptococcus pyogenes, abbreviated spCas9, is the most commonly used Cas9 variant. The reason for spCas9 popularity is two-fold. First the spCas9 PAM sequence is 5’-NGG, which is highly abundant in the genome allowing virtually any gene to be targeted. The spCas9 enzyme also has on average a higher efficiency in vivo compared to other variants. Cas9 Nuclease NLS contains a SV40 T antigen nuclear localization sequence (NLS) on the C-terminus of the protein. |
|
Cas9 Nuclease NLS Protein (Lyophilized)from ABM |
|
K151 | 200 µg (1.25 nmol): 295.00 EUR | |
Description: The Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9 system is the latest RNA-guided, endonuclease tool in genome editing which allows for very specific genomic disruption and replacement. The Cas9 nuclease serves to unwind the genomic DNA duplex next to conserved protospacer adjacent motifs (PAMs) and homes in on its target sequence, which is recognized by a complementary single-guide RNA. The resulting double-stranded break gets repaired by the non-homologous end joining (NHEJ) pathway, leading to a disruption in the open reading frame of the targeted gene. Alternatively, by supplying a suitable repair template, virtually any desired point mutation can be introduced at the break point via homology-directed repair (HDR).The Cas9 nuclease from the bacteria Streptococcus pyogenes, abbreviated spCas9, is the most commonly used Cas9 variant. The reason for spCas9 popularity is two-fold. First the spCas9 PAM sequence is 5’-NGG, which is highly abundant in the genome allowing virtually any gene to be targeted. The spCas9 enzyme also has on average a higher efficiency in vivo compared to other variants. Cas9 Nuclease NLS contains a SV40 T antigen nuclear localization sequence (NLS) on the C-terminus of the protein. |
|
Fungus-Derived Nuclease S1 Purifiedfrom Innovative research |
|
IFGS1NCL10KU | each: 100.00 EUR | |
Description: Fungus-Derived Nuclease S1 Purified |
|
Fungus-Derived Nuclease S1 Purifiedfrom Innovative research |
|
IFGS1NCL50KU | each: 247.00 EUR | |
Description: Fungus-Derived Nuclease S1 Purified |
|
Nuclease P1 from Penicillium citrinumfrom Jaica |
|
OPNUCP1 | 500 units/vial: 545.00 EUR | |
Nuclease P1 Antibody, Biotin conjugatedfrom Cusabio |
|
1-CSB-PA328459LD01PEU | [ 100ug: Ask for price ] [ 50ug: Ask for price ] | |
Description: A polyclonal antibody against Nuclease P1. Recognizes Nuclease P1 from Penicillium citrinum. This antibody is Biotin conjugated. Tested in the following application: ELISA |
|
saCas9 Nuclease NLS Protein (Lyophilized)from ABM |
|
K153 | 162.5 µg (1.25 nmol): 595.00 EUR | |
Description: The Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9 system is the latest RNA-guided endonuclease tool in genome editing which allows for very specific genomic disruption and replacement. The Cas9 nuclease serves to unwind the genomic DNA duplex next to conserved protospacer adjacent motifs (PAMs) and homes in on its target sequence, which is recognized by a complementary single-guide RNA. The resulting double-stranded break gets repaired by the non-homologous end joining (NHEJ) pathway, leading to a disruption in the open reading frame of the targeted gene. Alternatively, by supplying a suitable repair template, virtually any desired point mutation can be introduced at the break point via homology-directed repair (HDR).The Cas9 nuclease from the bacteria Staphylococcus aureus, abbreviated saCas9, is gaining popularity as an alternative to spCas9 due to its relatively smaller size. The saCas9 PAM sequence is 5’-NNGRRN (preferably 5’-NNGRRT). saCas9 Nuclease NLS contains a SV40 T antigen nuclear localization sequence (NLS) on the C-terminus of the protein.This saCas9 Nuclease NLS protein is offered as lyophilized powder for better long term storage and ambient temperature shipping. The protein is lyophilized as a low-salt powder, so it can be resuspended in your desired buffer for downstream applications. |
|
saCas9 Nuclease NLS Protein (Lyophilized)from ABM |
|
K152 | 32.5 µg (250pmol): 185.00 EUR | |
Description: The Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9 system is the latest RNA-guided endonuclease tool in genome editing which allows for very specific genomic disruption and replacement. The Cas9 nuclease serves to unwind the genomic DNA duplex next to conserved protospacer adjacent motifs (PAMs) and homes in on its target sequence, which is recognized by a complementary single-guide RNA. The resulting double-stranded break gets repaired by the non-homologous end joining (NHEJ) pathway, leading to a disruption in the open reading frame of the targeted gene. Alternatively, by supplying a suitable repair template, virtually any desired point mutation can be introduced at the break point via homology-directed repair (HDR).The Cas9 nuclease from the bacteria Staphylococcus aureus, abbreviated saCas9, is gaining popularity as an alternative to spCas9 due to its relatively smaller size. The saCas9 PAM sequence is 5’-NNGRRN (preferably 5’-NNGRRT). saCas9 Nuclease NLS contains a SV40 T antigen nuclear localization sequence (NLS) on the C-terminus of the protein.This saCas9 Nuclease NLS protein is offered as lyophilized powder for better long term storage and ambient temperature shipping. The protein is lyophilized as a low-salt powder, so it can be resuspended in your desired buffer for downstream applications. |
|
Human Apoptosis-enhancing nuclease (AEN)from Cusabio |
|
1-CSB-EP819883HU | [ 100ug: Ask for price ] [ 10ug: Ask for price ] [ 1MG: Ask for price ] [ 200ug: Ask for price ] [ 500ug: Ask for price ] [ 50ug: Ask for price ] | |
Description: Recombinant Human Apoptosis-enhancing nuclease(AEN),partial expressed in E.coli |
|
Cas9 Nuclease Protein (High Concentration)from ABM |
|
K108 | 40 µg (250pmol) Volume: 25µL: 80.00 EUR | |
Description: The Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9 system is the latest RNA-guided, endonuclease tool in genome editing which allows for very specific genomic disruption and replacement. ;;The Cas9 nuclease serves to unwind the genomic DNA duplex next to conserved protospacer adjacent motifs (PAMs) and homes in on its target sequence, which is recognized by a complementary single-guide RNA. The resulting double-stranded break gets repaired by the non-homologous end joining (NHEJ) pathway, leading to a disruption in the open reading frame of the targeted gene. Alternatively, by supplying a suitable repair template, virtually any desired point mutation can be introduced at the break point via homology-directed repair (HDR).;;The Cas9 nuclease from the bacteria Streptococcus pyogenes, abbreviated spCas9, is the most commonly used Cas9 variant. The reason for spCas9 popularity is two-fold. First the spCas9 PAM sequence is 5’-NGG, which is highly abundant in the genome allowing virtually any gene to be targeted. The spCas9 enzyme also has on average a higher efficiency in vivo compared to other variants. |